BIOADAPTIVES, INC. Quarterly Return On Equity in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bioadaptives, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2014 to Q3 2024.
  • Bioadaptives, Inc. Return On Equity for the quarter ending September 30, 2024 was 44.7 %, a 39.8% increase year-over-year.
  • Bioadaptives, Inc. annual Return On Equity for 2023 was 46.7 %, a 22.6% decline from 2022.
  • Bioadaptives, Inc. annual Return On Equity for 2022 was 60.3 %, a 32.5% decline from 2021.
  • Bioadaptives, Inc. annual Return On Equity for 2021 was 89.4 %, a 30.3% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 44.7 +12.7 +39.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 47.8 +1.46 +3.15% Apr 1, 2024 Jun 30, 2024
Q1 2024 46.7 -6.15 -11.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 46.7 -13.6 -22.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 32 -45.5 -58.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 46.3 -18.3 -28.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 52.9 -20.4 -27.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 60.3 -29.1 -32.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 77.5 -2.81 -3.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 64.6 -13.4 -17.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 73.2 -14.9 -16.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 89.4 +20.8 +30.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 80.3 +9.58 +13.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 78 -5.68 -6.79% Apr 1, 2021 Jun 30, 2021
Q1 2021 88.1 +19.8 +29% Dec 31, 2020 Mar 31, 2021
Q4 2020 68.6 +36 +110% Oct 1, 2020 Dec 31, 2020
Q3 2020 70.7 +1.99 +2.89% Jul 1, 2020 Sep 30, 2020
Q2 2020 83.7 -85.6 -50.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 68.3 -179 -72.4% Jan 1, 2020 Mar 31, 2020
Q4 2019 32.6 -342 -91.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 68.8 Jul 1, 2019 Sep 30, 2019
Q2 2019 169 Apr 1, 2019 Jun 30, 2019
Q1 2019 247 Jan 1, 2019 Mar 31, 2019
Q4 2018 374 Oct 1, 2018 Dec 31, 2018
Q3 2016 119 -2.89K -96% Jul 1, 2016 Sep 30, 2016
Q2 2016 126 -4.76K -97.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 176 -19.5K -99.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 171 +7.96K Oct 1, 2015 Dec 31, 2015
Q3 2015 3K Jul 1, 2015 Sep 30, 2015
Q2 2015 4.89K Apr 1, 2015 Jun 30, 2015
Q1 2015 19.7K Jan 1, 2015 Mar 31, 2015
Q4 2014 -7.79K Oct 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.